Impiricus’ Post

New whitepaper..... When reviewing your marketing tactics, does the activity seem more multichannel than omnichannel? According to many HCPs, that is the case with many pharma brands. Why? Perhaps it is because many brand initiatives are focused on a select number of publications, websites, and closed "doctor-only" social media apps. HCPs operate outside these ecosystems. When they need your valuable resources, you want to be there for them. When HCPs need fingertip access to your message and support, we help you be present where and when they need you most. #omnichannel #pharmamarketing #hcpengagement #impiricus

Video is king. When interacting with digital channels, Dr. Jill Farmer prefers videos, especially short mechanism of action clips. #Pharma #HCPs

Nobody wants to speak in riddles - but Dr. Jill Farmer says it happens too often when engaging with pharma reps. It can be just another hurdle to efficiently and effectively getting to patients. #Pharma #HCPs

Is there value in meeting with MSLs? Dr. Irina Robinson weighs in on a key difference between meeting with them and reps. #Pharma #HCPs

View our open roles: https://lnkd.in/edQFEEve

"That's another area in which I think the Pharmaceutical reps are very vital" Listen as Dr. Tamara Greene highlights one of the vital roles the reps play - helping doctors stay up to date on patient support programs. #Pharma #HCPs

Working with pharma it was amazing to see how little practicing physician voice was involved. We’re changing that. Watch the videos to see how pharma can truly serve physicians and patients.

Introducing the HCP Webinar Series. Hear physicians give their authentic views on the Pharma industry. Learn what doctors think about the future of Pharma-HCP engagement including rep interactivity, MSLs, patient support, and much more. Link to the series in the comments below. #hcp #pharma